A semiconductor package structure includes an electronic device having a first surface and an exposed region adjacent to the first surface; a dam disposed on the first surface and surrounding the exposed region of the electronic device; and a filter structure disposed on the dam.

The invention provides novel methods to place a complete package system filled with a sample into a light exposure chamber as a complete unit with periodic monitoring of the contents of the packaging system. Through this approach, it can be determined how the components of a complete package system perform collectively to influence its photoprotective performance enabling a first ever method to quantitate these impacts. In turn this will allow for package designs to be optimized for the photoprotection performances, for the impacts of packaging production defects to be explored, and for the influence of packaging form (e.g., surface area to volume ratio) to be determined. Such capabilities allow a first ever means to optimize package systems for photoprotective performance.

A method and system for measuring an amount of a gas dissolved in a liquid is described, in which the liquid is transferred to an equilibrator and in which the amount of the various gases is measured in the gas phase of the equilibrator and that a calculation of the amount of gas which is dissolved in the liquid is carried out.

A hydrogen sensor assembly includes a mounting portion; a sensor portion disposed adjacent to the mounting portion; and at least one pedestal connecting the sensor portion to the mounting portion, the sensor portion includes a metal oxide semiconductor having a hydrogen sensing surface and the hydrogen sensing surface includes a noble metal dopant.

Methods, apparatuses and systems for calibrating gas detectors are disclosed. An example calibration apparatus may have a gas supply element configured to provide a background gaseous substance within at least a portion of the calibration apparatus, a nebulizing element configured to generate the testing gaseous substance by transforming a testing solution in conjunction with the background gaseous substance, a pressure control element configured to regulate airflow in order to maintain a constant air pressure within the at least a portion of the calibration apparatus, and a controller component in electronic communication with the gas supply element, the nebulizing element and the pressure control element.

A quality control system analyzes the quality of a battery cell, with the battery cell defining a gas pouch configured to be filled with a gas. The quality control system includes a computational system including a processor and a memory, a manifold defining a passageway extending between an inlet port for receiving the gas and an outlet port, and at least one sensor in electronic communication with the computational system. The sensor is arranged to measure a physical property of the gas and transmit a signal to the computational system corresponding to the physical property of the gas. The computational system analyzes the physical property of the gas, accesses a threshold value corresponding to the physical property, compares the physical property to the threshold value, and assess a quality score for the battery cell. A corresponding method analyzes the quality of the battery cell with the quality control system.

A quality control system analyzes the quality of a battery cell, with the battery cell defining a gas pouch configured to expand from a deflated configuration to an inflated configuration when filled with a gas formed during a cell formation process. The system comprises a computational system comprising a processor and a memory and a measurement instrument in electronic communication with the computational system. The measurement instrument is arranged to measure a distance defined by the gas pouch and transmit a signal to the computational system corresponding to the distance. The computational system is arranged to analyze the distance with the processor and determine a volumetric measurement of the gas within the gas pouch and compare the volumetric measurement to a threshold in the memory to assess a quality score for the battery cell. A corresponding method analyzes the quality of the battery cell with the quality control system.

A method of analyzing the quality of a battery cell includes performing a high-throughput quality check on the battery cell with a quality control system, assessing a quality score to the battery cell, with quality score identifying the battery cell as low-quality or high-quality, and performing a comprehensive quality check on the battery cell if identified as low-quality. The method further includes assessing an enhanced quality score to the battery cell superseding the quality score of the quality control system identifying the battery cell as confirmed low-quality or confirmed high-quality and providing revised production instructions for manufacturing successive battery cells if confirmed low-quality.

The invention utilizes virtual screening strategy to seek for current market drugs as anti-schizophrenia therapy drug repurposing. Drug repurposing strategy finds new uses other than the original medical indications of existing drugs. Finding new indications for such drugs will benefit patients who are in needs for a potential new therapy sooner since known drugs are usually with acceptable safety and pharmacokinetic profiles. In this study, repurposing marketed drugs for DAAO inhibitor as new schizophrenia therapy was performed with virtual screening on marketed drugs and its metabolites. The identified and available drugs and compounds were further confirmed with in vitro DAAO enzymatic inhibitory assay.

The invention utilizes virtual screening strategy to seek for current market drugs as anti-schizophrenia therapy drug repurposing. Drug repurposing strategy finds new uses other than the original medical indications of existing drugs. Finding new indications for such drugs will benefit patients who are in needs for a potential new therapy sooner since known drugs are usually with acceptable safety and pharmacokinetic profiles. In this study, repurposing marketed drugs for DAAO inhibitor as new schizophrenia therapy was performed with virtual screening on marketed drugs and its metabolites. The identified and available drugs and compounds were further confirmed with in vitro DAAO enzymatic inhibitory assay.